Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. / Conti, Paola; De Amici, Marco; Joppolo Di Ventimiglia, Samuele; Stensbøl, Tine B; Madsen, Ulf; Bräuner-Osborne, Hans; Russo, Emilio; De Sarro, Giovambattista; Bruno, Giuseppe; De Micheli, Carlo.
In: Journal of Medicinal Chemistry, Vol. 46, No. 14, 03.07.2003, p. 3102-8.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids
AU - Conti, Paola
AU - De Amici, Marco
AU - Joppolo Di Ventimiglia, Samuele
AU - Stensbøl, Tine B
AU - Madsen, Ulf
AU - Bräuner-Osborne, Hans
AU - Russo, Emilio
AU - De Sarro, Giovambattista
AU - Bruno, Giuseppe
AU - De Micheli, Carlo
PY - 2003/7/3
Y1 - 2003/7/3
N2 - Bicyclic acidic amino acids (+/-)-6 and (+/-)-7, which are conformationally constrained homologues of glutamic acid, were prepared via a strategy based on a 1,3-dipolar cycloaddition. The new amino acids were tested toward ionotropic and metabotropic glutamate receptor subtypes; both of them behaved as antagonists at mGluR1,5 and as agonists at mGluR2. Furthermore, whereas (+/-)-6 was inactive at all ionotropic glutamate receptors, (+/-)-7 displayed a quite potent antagonism at the NMDA receptors. In the in vivo tests on DBA/2 mice, the compounds displayed an anticonvulsant activity. The interesting pharmacological profile of (+/-)-7 qualifies it as a lead of novel neuroprotective agents.
AB - Bicyclic acidic amino acids (+/-)-6 and (+/-)-7, which are conformationally constrained homologues of glutamic acid, were prepared via a strategy based on a 1,3-dipolar cycloaddition. The new amino acids were tested toward ionotropic and metabotropic glutamate receptor subtypes; both of them behaved as antagonists at mGluR1,5 and as agonists at mGluR2. Furthermore, whereas (+/-)-6 was inactive at all ionotropic glutamate receptors, (+/-)-7 displayed a quite potent antagonism at the NMDA receptors. In the in vivo tests on DBA/2 mice, the compounds displayed an anticonvulsant activity. The interesting pharmacological profile of (+/-)-7 qualifies it as a lead of novel neuroprotective agents.
KW - Amino Acids, Acidic
KW - Amino Acids, Dicarboxylic
KW - Animals
KW - Anticonvulsants
KW - CHO Cells
KW - Cerebral Cortex
KW - Cricetinae
KW - Crystallography, X-Ray
KW - Dicarboxylic Acids
KW - Excitatory Amino Acid Agonists
KW - Excitatory Amino Acid Antagonists
KW - Heterocyclic Compounds, 2-Ring
KW - Isoxazoles
KW - Male
KW - Mice
KW - Mice, Inbred DBA
KW - Molecular Conformation
KW - Rats
KW - Receptors, Metabotropic Glutamate
KW - Receptors, N-Methyl-D-Aspartate
KW - Stereoisomerism
U2 - 10.1021/jm0308085
DO - 10.1021/jm0308085
M3 - Journal article
C2 - 12825948
VL - 46
SP - 3102
EP - 3108
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 14
ER -
ID: 45596619